[Transient evoked otoacoustic emissions (TEOAE) in tinnitus patients treated with xylocaine]. / Przejsciowo wywolane emisje otoakustyczne (TEOAE) u pacjentów leczonych ksylokaina z powodu szumów usznych.

The group of patients suffering from tinnitus was treated with intravenous Xylocaine. Ten consecutive doses of Xylocaine (2 mg/kg b.m.) were administered during a period of ten days. Changes of amplitudes of TEOAE in relation to tinnitus suppression was assessed. In 91.5% of cases we observed correlation between amplitude changes and complaint abatement. Both amplitude changes and the time of tinnitus suppression increased after ten days of treatment in comparison with single dose of Xylocaine. The differences of amplitude variations between tinnitus and non tinnitus ear group was statistically significant (Wilcoxon test p < 0.05). The treatment with Xylocaine was considered to be the beginning of long-term procedure aimed at causing habituation of tinnitus in patients conscience (TRT).

[Low-power laser in the treatment of tinnitus--a placebo-controlled study]. / Laser niskoenergetyczny w leczeniu szumów usznych--badania porównawcze z placebo.

The present study was performed on 32 patients in order to investigate the effect of low-power laser on their tinnitus. The patients were divided into two groups. One group received laser therapy and the other was given a placebo procedure. The effect was evaluated by the use of visual analogue scales. Within the patient group transiently evoked otoacoustic emissions (TEOAE) were measured before, during and after therapy. No significant difference between laser and placebo was found in annoyance or loudness of the tinnitus and in changes of TEOAE amplitude. These results indicate that there is no relationship between the effect of low-power laser and changes in cochlear micromechanics.

[Evoked otoacoustic emissions in the neonatal hearing screening]. / Zastosowanie wywolanych emisji otoakustycznych w badaniu przesiewowym sluchu u noworodków.

Early identification of hearing impairment in children is a major problem for clinical research and development. Transient click evoked otoacoustic emissions (TEOAE) have been shown to be a useful test of hearing impairment, especially when used for infant screening. The purpose of this study was evaluation of transiently evoked otoacoustic emissions (TEOAE) for the two-stage screening of infant hearing. The first stage was measurement of otoacoustic emissions. TEOAE were performed in 200 infants. 17.5% of the children exhibited risk factors for hearing impairment. Those failing the second stage proceeded to auditory brain-stem response (ABR). The absence of TEOAE in both ears in 2 children was detected by ABR. The data obtained show that two stage newborn hearing screening is practicable, effective, low-cost and safe.